UNSPSC 85872860: Fluoroscopy of superior mesenteric artery using low osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of superior mesenteric artery using low osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B4141ZZ

UNSPSC 85872860 Fluoroscopy of superior mesenteric artery using low osmolar contrast is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific radiological diagnostic procedure using contrast media, yet the three most recent opportunities tagged to this code involve Picture Archiving and Communication Systems (PACS) procurement, special education contracted services, and temporary health professional staffing — none of which involve fluoroscopy or contrast administration as a direct procurement line item. The mismatch suggests either misclassification at the point of posting or that state and local procurement offices are using this code as a catch-all for health system diagnostic and clinical services without precise commodity-level granularity.

The geographic spread of the limited activity spans California (San Mateo County Medical Center and Santa Clara County Health System) and Texas (Birdville Independent School District), with no concentration pattern evident from only three records. Representative recent opportunities include San Mateo Medical Center's PACS system RFP (due October 21, 2026) seeking enterprise-grade imaging software with EPIC integration and HIPAA compliance, and Santa Clara County Health System's non-exclusive qualified vendor pool for temporary health professional staffing (RFQ, due October 7, 2026) covering diagnostic imaging and radiology among thirteen ancillary clinical categories. Neither opportunity directly procures fluoroscopy procedures or contrast media. The code shows little relevant recent activity for vendors targeting fluoroscopy service delivery or contrast product sales to state and local health systems.